Keqiang Xie

机构：Scripps Research Institute, Fulcrum Therapeutics (United States), Full Circle Research (United States), Huazhong University of Science and Technology, Ministry of Industry and Information Technology · ORCID：0009-0007-8320-5165

发表论文 51 篇 · 总被引 1954 次 · h-index 21

代表论文

• THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets (2021 · British Journal of Pharmacology · 被引 277)
• The Concise Guide to PHARMACOLOGY 2023/24: Introduction and Other Protein Targets (2023 · British Journal of Pharmacology · 被引 218)
• Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration (2024 · Nature Biotechnology · 被引 34)
• NF1-cAMP signaling dissociates cell type–specific contributions of striatal medium spiny neurons to reward valuation and motor control (2019 · PLoS Biology · 被引 21)
• Inhibition of PDE2 and PDE4 synergistically improves memory consolidation processes (2020 · Neuropharmacology · 被引 16)
• A denoising diffusion probabilistic model-based fault sample generation approach for imbalanced intelligent fault diagnosis (2025 · Measurement Science and Technology · 被引 10)